
Antibody Therapeutics
Generate, prioritize, or optimize antibody and biologics candidates.
Route into development-aware workflows for assay-ready hit panels, defensible leads, PCC nomination, optimization, specificity de-risking, complex constructs, and conjugate decisions.
- Target-to-Hit
- Target-to-Lead
- PCC Selection
- Lead Optimization
- Epitope De-risking
- Bispecific Support
- ADC / Conjugate Support

